Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients

Figure 1

BOS-free survival in 107 lung transplant recipients related to CMV disease. No CMV infection (n = 65), Asymptomatic CMV infection (n = 11), CMV disease (n = 31). BOS-free 4 year survival for patients with CMV disease was 32%, (p = 0.005), for asymptomatic CMV infection 36%, (p = 0.061) as compared with patients without CMV infection (69%).

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us